Aduro Clean Technologies annonce sa participation à une série de conférences d’investisseurs
March 26, 2025 01:12 ET
|
Aduro Clean Technologies Inc.
LONDON, Ontario, 26 mars 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (« Aduro » ou la « société ») (Nasdaq : ADUR) (CSE : ACT) (FSE : 9D5), une société du secteur des technologies propres...
Aduro Clean Technologies auf kommenden Investorenkonferenzen vertreten
March 26, 2025 01:12 ET
|
Aduro Clean Technologies Inc.
LONDON, Ontario, March 26, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. („Aduro“ oder das „Unternehmen“) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), ein Unternehmen für umweltfreundliche...
Humacyte, Inc. Announces Pricing of Public Offering of Common Stock
March 25, 2025 20:35 ET
|
Humacyte, Inc
DURHAM, N.C., March 25, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at...
Qifu Technology, Inc. Announces Pricing of Offering of US$600 Million Cash-par Settled Convertible Senior Notes
March 25, 2025 20:02 ET
|
Qifu Technology, Inc.
SHANGHAI, China, March 25, 2025 (GLOBE NEWSWIRE) -- Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading AI-empowered Credit-Tech platform in China, today...
Ascentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2025
March 25, 2025 19:00 ET
|
ASCENTAGE PHARMA GROUP INTERNATIONAL
ROCKVILLE, Md. and SUZHOU, China, March 25, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and...
Biomea Fusion Announces Leadership Transition
March 25, 2025 19:00 ET
|
Biomea Fusion, Inc.
Board member Mick Hitchcock named interim CEO replacing Thomas Butler.COO and President Ramses Erdtmann continuing at Biomea in current role.REDWOOD CITY, Calif., March 25, 2025 (GLOBE NEWSWIRE) --...
REEオートモーティブ、大手テクノロジー企業とソフトウェア定義技術に関する覚書（MOU）を締結、今後数年にわたる大規模自動運転車両フレームワーク合意への道を開く
March 25, 2025 18:30 ET
|
REE Automotive Ltd.
REEは、複数の国際市場において、同大手テクノロジー企業のソフトウェア定義型車両技術の独占プロバイダーとなる意向である。長期業務提携の最終契約は2025年に締結予定。2027年の生産開始を経て、2030年までにREEのP7プラットフォームのメリットを最大限に活用した自動運転車両数千台の納品を予定している。2025年下半期からソフトウェアとサービスの収益化を開始、2030年までに戦略的提携契約による...
CSX Announces Tentative Labor Agreement with Boilermakers
March 25, 2025 18:01 ET
|
CSX Corporation
JACKSONVILLE, Fla., March 25, 2025 (GLOBE NEWSWIRE) -- CSX Corporation (NASDAQ: CSX) today announced it has secured a new five-year tentative collective bargaining agreement with the International...
Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
March 25, 2025 18:00 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Theratechnologies Receives FDA Approval for EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and Lipodystrophy
March 25, 2025 17:45 ET
|
Theratechnologies
New, improved formulation set to replace EGRIFTA SV® MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a...